Deal Type
Industry
Deal Status
Interested in Healthcare R&D, Bio Tech, Diagnostic, Pharmaceutical, HealthTech, Healthcare Fintech companies, Nutrition Supplements, and any other verticals in the health space. The fund will invest only in Growth stage companies. Criteria: Revenue of 20 to 30 Cr Need to be EBITDA positive Future plan for growth in case EBITDA is weak. Their investment size is between $7 to $15 M, sweet spot being $10 M.
No Files Attached